PRIME DIABETES HEART NUTRITION
Aab04-002	High Dose NAC
	Quote:	Boosts glutathione production. 600mg low dose long term support. 1200mg 30 - 90 dayshelps overcome issues. 14 days, 2,000 aggressive support of healing. not every supplement is right for every person.
	Comment:	Some MCS victems swear by it. Not all benefit from it. it jsut depends where you are biochemically broken inside.
	Article:	http://youtube.com/watch?v9foOavZyLrg
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
DIABETES MICROBIOME
Mdb04-004	Stage-specific gut microbiome shifts across the Type 2 Diabetes Mellitus spectrum: A systematic review and meta-analysis
	Quote:	Conclusion Gut microbiome alterations are subtle and inconsistent in early dysglycemia but become pronounced and reproducible with diabetic complications, suggesting microbiome-based biomarkers may be most clinically useful for identifying disease progression rather than early detection. Limitations include heterogeneity of sequencing methods and reliance on 16S rRNA data, which may restrict taxonomic and functional resolution. To our knowledge, this is the first meta-analysis to systematically evaluate gut microbiome alterations across multiple clinical stages of type 2 diabetes progression.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.01.20.25341999v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.01.20.25341999v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Sanaa Harrass Shaimaa Ali Mariam Elshweikh Ricardo Franco-Duarte Thilini N. Jayasinghe,
DIABETES
Mdb04-024	Characterisation of diabetes-associated adipose tissue dysfunction across the spectrum of body mass index
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.01.26.26344859v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.01.26.26344859v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Oliver Brown Derek Magee Michael Drozd Marcella Conning-Rowland Marilena Giannoudi Aya Shouma Alexander-Francisco Bruns Natalie J Haywood Lee D Roberts Joanna Kalucka Samuel Relton Mark T Kearney Kathryn J Griffin Richard M Cubbon,
DIABETES
Mdb04-026	Continuous Glucose Monitoring in Older In-patients with Type 2 Diabetes and Cognitive Impairment: A feasibility study
	Quote:	Conclusion CGM use in older in-patients with T2DM and cognitive impairment is highly feasible and acceptable for patients. Future studies and trials are now needed to evaluate the clinical use of CGM for glucose monitoring in hospitalised or community-dwelling older individuals with T2DM and cognitive impairment.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.01.26.26344013v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.01.26.26344013v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Busra Donat Ergin Katharina Mattishent Anne M Minihane Richard Holt Helen R Murphy Ketan Dhatariya Michael Hornberger,
DIABETES GENETICS
Mge04-002	Disentangling Type 2 Diabetes Risk and Comorbidity Using Genomic Structural Equation Modeling
	Quote:	Phenome-wide and comorbidity analyses revealed that each latent factor PGS associated with specific T2D-related complications and provided broader or distinct associations compared with conventional metabolic PGSs, with the obesity and lifestyle-related factor showing the widest impact. These findings illustrate how multivariate genetic approaches can disentangle the biological heterogeneity of T2D, refine polygenic risk prediction, and reveal mechanistic pathways driving divergent patterns of disease and comorbidity.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.01.26.26344825v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.01.26.26344825v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Merli Koitme Kristi Lll Mrt Mls Andrew P Morris Krista Fischer Reedik Mgi,

Updated weekly. 01/31/2026-02:32:41 AM
Javilk's Research Links
Drop me a note to subscribe.
What interests you?

Aab04-002

High Dose NAC

Mdb04-004

Stage-specific gut microbiome shifts across the Type 2 Diabetes Mellitus spectrum: A systematic review and meta-analysis

Mdb04-024

Characterisation of diabetes-associated adipose tissue dysfunction across the spectrum of body mass index

Mdb04-026

Continuous Glucose Monitoring in Older In-patients with Type 2 Diabetes and Cognitive Impairment: A feasibility study

Mge04-002

Disentangling Type 2 Diabetes Risk and Comorbidity Using Genomic Structural Equation Modeling